[HTML][HTML] A distinct DNA methylation shift in a subset of glioma CpG island methylator phenotypes during tumor recurrence

CF de Souza, TS Sabedot, TM Malta, L Stetson… - Cell reports, 2018 - cell.com
Glioma diagnosis is based on histomorphology and grading; however, such classification
does not have predictive clinical outcome after glioblastomas have developed. To date, no …

A Distinct DNA Methylation Shift in a Subset of Glioma CpG Island Methylator Phenotypes during Tumor Recurrence.

CF de Souza, TS Sabedot, TM Malta, L Stetson… - Cell Reports, 2018 - europepmc.org
Glioma diagnosis is based on histomorphology and grading; however, such classification
does not have predictive clinical outcome after glioblastomas have developed. To date, no …

[HTML][HTML] A Distinct DNA Methylation Shift in a Subset of Glioma CpG Island Methylator Phenotypes during Tumor Recurrence

CF de Souza, TS Sabedot, TM Malta, L Stetson… - Cell Reports, 2018 - Elsevier
Glioma diagnosis is based on histomorphology and grading; however, such classification
does not have predictive clinical outcome after glioblastomas have developed. To date, no …

A Distinct DNA Methylation Shift in a Subset of Glioma CpG Island Methylator Phenotypes during Tumor Recurrence

CF de Souza, TS Sabedot, TM Malta, L Stetson… - CELL …, 2018 - bv.fapesp.br
Glioma diagnosis is based on histomorphology and grading; however, such classification
does not have predictive clinical outcome after glioblastomas have developed. To date, no …

[PDF][PDF] A Distinct DNA Methylation Shift in a Subset of Glioma CpG Island Methylator Phenotypes during Tumor Recurrence

CF de Souza, TS Sabedot, TM Malta, L Stetson… - scholarlycommons.henryford.com
Glioma diagnosis is based on histomorphology and grading; however, such classification
does not have predictive clinical outcome after glioblastomas have developed. To date, no …

A Distinct DNA Methylation Shift in a Subset of Glioma CpG Island Methylator Phenotypes during Tumor Recurrence

CF de Souza, TS Sabedot, TM Malta… - Cell …, 2018 - pubmed.ncbi.nlm.nih.gov
Glioma diagnosis is based on histomorphology and grading; however, such classification
does not have predictive clinical outcome after glioblastomas have developed. To date, no …

[HTML][HTML] A Distinct DNA Methylation Shift in a Subset of Glioma CpG Island Methylator Phenotypes during Tumor Recurrence

CF de Souza, TS Sabedot, TM Malta, L Stetson… - Cell Reports, 2018 - cell.com
Glioma diagnosis is based on histomorphology and grading; however, such classification
does not have predictive clinical outcome after glioblastomas have developed. To date, no …

[引用][C] A Distinct DNA Methylation Shift in a Subset of Glioma CpG Island Methylator Phenotypes during Tumor Recurrence

CF de Souza, TS Sabedot, TM Malta, L Stetson… - Cell Reports, 2018 - cir.nii.ac.jp
A Distinct DNA Methylation Shift in a Subset of Glioma CpG Island Methylator Phenotypes
during Tumor Recurrence | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] …

[PDF][PDF] A Distinct DNA Methylation Shift in a Subset of Glioma CpG Island Methylator Phenotypes during Tumor Recurrence

CF de Souza, TS Sabedot, TM Malta, L Stetson… - Cell …, 2018 - repositorio.usp.br
Glioma diagnosis is based on histomorphology and grading; however, such classification
does not have predictive clinical outcome after glioblastomas have developed. To date, no …

[PDF][PDF] A Distinct DNA Methylation Shift in a Subset of Glioma CpG Island Methylator Phenotypes during Tumor Recurrence

CF de Souza, TS Sabedot, TM Malta, L Stetson… - Cell …, 2018 - researchgate.net
Glioma diagnosis is based on histomorphology and grading; however, such classification
does not have predictive clinical outcome after glioblastomas have developed. To date, no …